Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug
The four dose levels of the therapy assessed in the trial were well-tolerated by the subjects.
Clinical Trials
Medidata extends partnership with Tigermed to enhance clinical trial processes
Intellia doses first subject in trial of NTLA-2002 for hereditary angioedema
Rigel enrols first subject in Phase I sickle cell disease therapy trial
Tris Pharma reports positive data from Phase III acute pain therapy trial
Sonnet BioTherapeutics to expand trial of SON-1010 with trabectedin for solid tumours
Advarra introduces Study Collaboration to help improve trial partnership
FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug
